-
DAIICHI SANKYO COMPANY, LIMITED et al v. MYLAN PHARMACEUTICALS, INC. et al DC
- 2:06-cv-03462
- D.N.J.
- Judge: William J. Martini
+1
- Filed: 07/31/2006
- Closed: 08/06/2009
- Latest Docket Entry: 10/20/2016
- PACER
- Docket updated daily
2
Plaintiffs
2
Defendants
1
Accused
Product
1
Patent-in-Suit
1,103
Days in
Litigation
-
DAIICHI SANKYO COMPANY, LIMITED et al v. MYLAN PHARMACEUTICALS, INC. et al DC
- 2:06-cv-03462
- D.N.J.
- Judge: William J. Martini
+1
- Filed: 07/31/2006
- Closed: 08/06/2009
- Latest Docket Entry: 10/20/2016
- PACER
- Docket updated daily
Cause of Action
Infringement
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
| Claim # | Claim Text | Outcome |
|---|---|---|
| 13 |
The compound of claim 1, selected from the group consisting of (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{4-[2-(tetrazol-5-yl)phenyl]phenyl} methylimidazole-5-carboxylate and pharmaceutically acceptable salts
view more
|
Enforceable and Valid (103)
Entry 139 |
-
Infringement
Matrix Laboratories Limited
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Olmesartan Medoxomil tablets 20 mgOlmesartan Medoxomil tablets 40 mgOlmesartan Medoxomil tablets 5 mg | US 5,616,599 A |
13
|
Infringement
Entry 139
|
Mylan Laboratories Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 20 mg40 mgOlmesartan Medoxomil tablets 20 mgOlmesartan Medoxomil tablets 40 mgOlmesartan Medoxomil tablets 5 mg | US 5,616,599 A |
13
|
Infringement
Entry 143Entry 139 |
Mylan Pharmaceuticals Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 20 mg40 mgOlmesartan Medoxomil tablets 20 mgOlmesartan Medoxomil tablets 40 mgOlmesartan Medoxomil tablets 5 mg | US 5,616,599 A |
13
|
Infringement
Entry 143Entry 139 |
